between the CpG sites in humans and rats (3) then this approach might not produce data that could be applied to humans.
Professor Dimitriou (see Ref. 1) raises an important point about the I/D polymorphism and either allele (the I or D) being in linkage disequilibrium with promoter variants that might be susceptible to methylation. I would add that the potentially changeable methylation status of the ACE promoter justifies my assertion that the epigenetic regulation might be more important than the polymorphism.
Finally, I would like to say that I have found the Journal of Applied Physiology's Viewpoint format an excellent forum for open debate. I also thank each of the authors who have provided commentaries for their valued and expert opinions.
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